|
WSB2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.016600E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.356500E-04 |
| Normal-vs-Stage2 |
3.617000E-01 |
| Normal-vs-Stage3 |
1.76340999999969E-05 |
| Normal-vs-Stage4 |
1.65289999998208E-06 |
| Stage1-vs-Stage2 |
5.601200E-03 |
| Stage1-vs-Stage3 |
1.446390E-01 |
| Stage1-vs-Stage4 |
2.191800E-02 |
| Stage2-vs-Stage3 |
7.809000E-04 |
| Stage2-vs-Stage4 |
1.589110E-04 |
| Stage3-vs-Stage4 |
3.179000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.85769999996965E-06 |
| Normal-vs-AfricanAmerican |
1.871420E-01 |
| Normal-vs-Asian |
5.760500E-04 |
| Caucasian-vs-AfricanAmerican |
1.763220E-01 |
| Caucasian-vs-Asian |
6.626600E-01 |
| AfricanAmerican-vs-Asian |
1.389200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.06410000000079E-05 |
| Normal-vs-Female |
1.421120E-03 |
| Male-vs-Female |
1.168950E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.204260E-03 |
| Normal-vs-Age(41-60Yrs) |
1.391720E-04 |
| Normal-vs-Age(61-80Yrs) |
8.347600E-02 |
| Normal-vs-Age(81-100Yrs) |
3.147600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.942200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.724200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.271400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.044980E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.130600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.016400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.073800E-01 |
| Classical-VS-Follicular |
2.63690003166062E-09 |
| Classical-VS-Other |
9.551400E-01 |
| Classical-VS-Normal |
1.13789999978131E-07 |
| Tall-VS-Follicular |
3.40009997934487E-09 |
| Tall-VS-Other |
5.627400E-01 |
| Tall-VS-Normal |
4.51010000013241E-07 |
| Follicular-VS-Other |
5.533700E-02 |
| Follicular-VS-Normal |
1.361580E-02 |
| Other-VS-Normal |
2.213800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.865800E-02 |
| Normal-vs-N1 |
6.51429998832498E-09 |
| N0-vs-N1 |
1.69974999999489E-05 |
|
|
